Justin Dye insider trades: Medicine Man Technologies (SHWZ) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Justin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | SHWZ | ↑ Buy | 500,000 | $1.50 | $750K | Indirect | Feb 15, 2023 (2d) |
| May 20, 2020 | MDCL | ↑ Buy | 187,500 | $2.00 | $375K | Indirect | May 22, 2020 (2d) |
| Jun 16, 2019 | MDCL | ↑ Buy | 3,500,000 | $2.00 | $7.0M | Indirect | Jul 24, 2019 (38d) |
| Jun 5, 2019 | MDCL | ↑ Buy | 1,500,000 | $2.00 | $3.0M | Indirect | Jun 17, 2019 (12d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Justin Dye's insider trades
Justin Dye is a director at Medicine Man Technologies (SHWZ). Since Jun 5, 2019, Justin has reported 4 open-market purchases worth $11.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), other transactions (5 filings), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SHWZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.